The company has received approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Hikma Pharmaceuticals USA Inc product, Alembic Pharmaceuticals said in a statement.from Moneycontrol Business News https://ift.tt/M4QHK6W
Comments
Post a Comment